WA
SNY icon

Whipplewood Advisors’s Sanofi SNY Stock Holding History

Whipplewood Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48K Sell
105
-682
-87% -$30.5K ﹤0.01% 325
2026
Q1 		$37.9K Buy
787
+751
+2,086% +$35K 0.02% 304
2025
Q4 		$1.75K Buy
+36
New +$1.78K ﹤0.01% 353
2025
Q3 		– Sell
-1,606
Closed -$77.6K – 1027
2025
Q2 		$77.6K Buy
1,606
+247
+18% +$12.6K 0.04% 267
2025
Q1 		$88.5K Sell
1,359
-220
-14% -$11.9K 0.05% 239
2024
Q4 		$76.2K Buy
+1,579
New +$80.3K 0.04% 255

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Whipplewood Advisors's SNY Position: Q2 2026 in Review

Whipplewood Advisors reduced its Sanofi (SNY) stake by 87% in Q2 2026, selling an estimated $30.5K and leaving 105 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Whipplewood Advisors first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $88.5K in Q1 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Whipplewood Advisors held 105 shares of Sanofi worth $4.48K as of Q2 2026.
  • Whipplewood Advisors sold 682 Sanofi shares in Q2 2026, an estimated $30.5K.
  • Sanofi made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #325 holding.
  • Whipplewood Advisors first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's Sanofi position peaked at $88.5K in Q1 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.